Pre-order Enquiry
Request Free Sample
Global Opioid-Induced Constipation (OIC) Treatment Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17246792 | Publishing Date : 22-Jan-2021 | No. of pages : 96
Detailed TOC of Global Opioid-Induced Constipation (OIC) Treatment Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Parenteral (Subcutaneous Injection)
1.3 Market by Application
1.3.1 Global Opioid-Induced Constipation (OIC) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drug Store
1.3.3 Independent Pharmacies
1.3.4 Hospital Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Perspective (2016-2027)
2.2 Opioid-Induced Constipation (OIC) Treatment Growth Trends by Regions
2.2.1 Opioid-Induced Constipation (OIC) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Opioid-Induced Constipation (OIC) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Opioid-Induced Constipation (OIC) Treatment Industry Dynamic
2.3.1 Opioid-Induced Constipation (OIC) Treatment Market Trends
2.3.2 Opioid-Induced Constipation (OIC) Treatment Market Drivers
2.3.3 Opioid-Induced Constipation (OIC) Treatment Market Challenges
2.3.4 Opioid-Induced Constipation (OIC) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue
3.1.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue (2016-2021)
3.1.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Opioid-Induced Constipation (OIC) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Opioid-Induced Constipation (OIC) Treatment Revenue
3.4 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio
3.4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid-Induced Constipation (OIC) Treatment Revenue in 2020
3.5 Opioid-Induced Constipation (OIC) Treatment Key Players Head office and Area Served
3.6 Key Players Opioid-Induced Constipation (OIC) Treatment Product Solution and Service
3.7 Date of Enter into Opioid-Induced Constipation (OIC) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid-Induced Constipation (OIC) Treatment Breakdown Data by Type
4.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Type (2022-2027)
5 Opioid-Induced Constipation (OIC) Treatment Breakdown Data by Application
5.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
6.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type
6.2.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
6.2.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
6.2.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
6.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application
6.3.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
6.3.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
6.3.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
6.4 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country
6.4.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021)
6.4.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
7.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type
7.2.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
7.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application
7.3.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
7.4 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country
7.4.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type
8.2.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application
8.3.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region
8.4.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
9.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type
9.2.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
9.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application
9.3.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
9.4 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country
9.4.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type
10.2.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application
10.3.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country
10.4.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Introduction
11.2.4 AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Opioid-Induced Constipation (OIC) Treatment Introduction
11.3.4 Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 S.L.A. Pharma
11.4.1 S.L.A. Pharma Company Details
11.4.2 S.L.A. Pharma Business Overview
11.4.3 S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Introduction
11.4.4 S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.4.5 S.L.A. Pharma Recent Development
11.5 AIKO Biotechnology
11.5.1 AIKO Biotechnology Company Details
11.5.2 AIKO Biotechnology Business Overview
11.5.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Introduction
11.5.4 AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.5.5 AIKO Biotechnology Recent Development
11.6 Cubist Pharmaceuticals
11.6.1 Cubist Pharmaceuticals Company Details
11.6.2 Cubist Pharmaceuticals Business Overview
11.6.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction
11.6.4 Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.6.5 Cubist Pharmaceuticals Recent Development
11.7 Salix Pharmaceuticals
11.7.1 Salix Pharmaceuticals Company Details
11.7.2 Salix Pharmaceuticals Business Overview
11.7.3 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction
11.7.4 Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.7.5 Salix Pharmaceuticals Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Details
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Introduction
11.8.4 Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.8.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Opioid-Induced Constipation (OIC) Treatment Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Parenteral (Subcutaneous Injection)
Table 4. Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2016-2021)
Table 8. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2022-2027)
Table 10. Opioid-Induced Constipation (OIC) Treatment Market Trends
Table 11. Opioid-Induced Constipation (OIC) Treatment Market Drivers
Table 12. Opioid-Induced Constipation (OIC) Treatment Market Challenges
Table 13. Opioid-Induced Constipation (OIC) Treatment Market Restraints
Table 14. Global Opioid-Induced Constipation (OIC) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Players (2016-2021)
Table 16. Global Top Opioid-Induced Constipation (OIC) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid-Induced Constipation (OIC) Treatment as of 2020)
Table 17. Ranking of Global Top Opioid-Induced Constipation (OIC) Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Opioid-Induced Constipation (OIC) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Opioid-Induced Constipation (OIC) Treatment Product Solution and Service
Table 21. Date of Enter into Opioid-Induced Constipation (OIC) Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Opioid-Induced Constipation (OIC) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. GlaxoSmithKline Company Details
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Product
Table 64. GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 65. GlaxoSmithKline Recent Development
Table 66. AstraZeneca Company Details
Table 67. AstraZeneca Business Overview
Table 68. AstraZeneca Opioid-Induced Constipation (OIC) Treatment Product
Table 69. AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 70. AstraZeneca Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Opioid-Induced Constipation (OIC) Treatment Product
Table 74. Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. S.L.A. Pharma Company Details
Table 77. S.L.A. Pharma Business Overview
Table 78. S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Product
Table 79. S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 80. S.L.A. Pharma Recent Development
Table 81. AIKO Biotechnology Company Details
Table 82. AIKO Biotechnology Business Overview
Table 83. AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Product
Table 84. AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 85. AIKO Biotechnology Recent Development
Table 86. Cubist Pharmaceuticals Company Details
Table 87. Cubist Pharmaceuticals Business Overview
Table 88. Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product
Table 89. Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 90. Cubist Pharmaceuticals Recent Development
Table 91. Salix Pharmaceuticals Company Details
Table 92. Salix Pharmaceuticals Business Overview
Table 93. Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product
Table 94. Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 95. Salix Pharmaceuticals Recent Development
Table 96. Takeda Pharmaceutical Company Details
Table 97. Takeda Pharmaceutical Business Overview
Table 98. Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 99. Takeda Pharmaceutical Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Parenteral (Subcutaneous Injection) Features
Figure 4. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Application: 2020 VS 2027
Figure 5. Drug Store Case Studies
Figure 6. Independent Pharmacies Case Studies
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Opioid-Induced Constipation (OIC) Treatment Report Years Considered
Figure 9. Global Opioid-Induced Constipation (OIC) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Opioid-Induced Constipation (OIC) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2022-2027)
Figure 13. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Players in 2020
Figure 14. Global Top Opioid-Induced Constipation (OIC) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid-Induced Constipation (OIC) Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Opioid-Induced Constipation (OIC) Treatment Revenue in 2020
Figure 16. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
Figure 20. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
Figure 21. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027)
Figure 22. United States Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
Figure 26. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
Figure 27. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027)
Figure 28. Germany Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Region (2016-2027)
Figure 38. China Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 58. AstraZeneca Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 60. S.L.A. Pharma Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 61. AIKO Biotechnology Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 62. Cubist Pharmaceuticals Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 63. Salix Pharmaceuticals Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Keyplayers in Global Opioid-Induced Constipation (OIC) Treatment Market Size, Status and Forecast 2021-2027
GlaxoSmithKlineAstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical
Request Sample
Request Discount
